SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000930413-15-004681
Filing Date
2015-12-08
Accepted
2015-12-08 07:30:50
Documents
12
Period of Report
2015-10-31

Document Format Files

Seq Description Document Type Size
1 c83212_10q.htm 10-Q 476677
2 c83212_ex10-t.htm EX-10.T 43928
3 c83212_ex31-1.htm EX-31.1 8985
4 c83212_ex31-2.htm EX-31.2 8977
5 c83212_ex32-1.htm EX-32.1 3073
6 c83212_ex32-2.htm EX-32.2 3111
  Complete submission text file 0000930413-15-004681.txt   3451654

Data Files

Seq Description Document Type Size
7 enz-20151031.xml EX-101.INS 567927
8 enz-20151031.xsd EX-101.SCH 51701
9 enz-20151031_cal.xml EX-101.CAL 43414
10 enz-20151031_def.xml EX-101.DEF 212072
11 enz-20151031_lab.xml EX-101.LAB 321645
12 enz-20151031_pre.xml EX-101.PRE 223074
Mailing Address ENZO BIOCHEM INC 60 EXECUTIVE BLVD FARMINGDALE NY 11735
Business Address 60 EXECUTIVE BLVD FARMINGDALE NY 11735 5167555500
ENZO BIOCHEM INC (Filer) CIK: 0000316253 (see all company filings)

IRS No.: 132866202 | State of Incorp.: NY | Fiscal Year End: 0731
Type: 10-Q | Act: 34 | File No.: 001-09974 | Film No.: 151274056
SIC: 8071 Services-Medical Laboratories